A phase 2 clinical trial has started, with the first patient dosed, to evaluate a treatment for metastatic colorectal cancer. However, reports are unclear on the specifics of the trial, with some outlets mentioning different treatments and conditions, such as chemotherapy induced peripheral neuropathy, vitiligo, and breast cancer. The details of the trial, including the treatment being tested, remain uncertain.